Homologous recombination repair (HRR) alterations may be passenger events in patients with advanced prostate cancer (PC) with high tumor mutational burden (hTMB).

被引：0
|
作者：
Bhatlapenumarthi, Vineel
De Sarkar, Navonil
Patwari, Anannya
Antonarakis, Emmanuel S.
Nelson, Ariel Ann
Kilari, Deepak
机构：
[1] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI USA
[2] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI USA
[3] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI USA
[4] Univ Minnesota, Masonic Canc Ctr, Dept Med, Minneapolis, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-180; 283-11574; 3282-206-4957-326-5041; 261-566-3248-9542-9243; 3282-206-2798; 6; 4; 3; 2; 38092-33482; 38092-18853; 38092-31362; 38092-18852; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.206
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：206 / 206
页数：1
相关论文
共 50 条
  • [1] DNA damaging therapies in patients (pts) with prostate cancer (PC) and pathogenic alterations in homologous recombination repair (HRR) genes.
    Graham, Laura
    Green, Edward
    Park, Joseph J.
    Kellezi, Olesia
    Hwang, Clara
    Barata, Pedro C.
    Bilen, Mehmet Asim
    Kilari, Deepak
    Clingerman, Melissa
    Tripathi, Abhishek
    Labriola, Matthew
    Rothstein, Shoshana
    Garje, Rohan
    Koshkin, Vadim S.
    Patel, Vaibhav G.
    Dorff, Tanya B.
    Armstrong, Andrew J.
    Mckay, Rana R.
    Alva, Ajjai Shivaram
    Schweizer, Michael Thomas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [2] Homologous Recombination Repair Gene Alterations Are Associated with Tumor Mutational Burden and Survival of Immunotherapy
    Ito, Mamoru
    Kubo, Makoto
    Kawaji, Hitomi
    Otsubo, Yoshiki
    Kurata, Kanako
    Abutani, Hikaru
    Suyama, Mikita
    Oda, Yoshinao
    Yoshizumi, Tomoharu
    Nakamura, Masafumi
    Baba, Eishi
    [J]. CANCERS, 2023, 15 (23)
  • [3] Identification of homologous recombination and repair (HRR) deficiency using circulating tumor DNA (ctDNA) in advanced prostate cancer (aPC).
    Bucheit, Leslie A.
    Yen, Jennifer
    Drusbosky, Leylah
    Barbacioru, Catalin
    Gnerre, Sante
    Wang, Hao
    Artyomenko, Alexander
    Yabolonovitch, Arielle
    Fu, Yu
    Lee, Che-Yu
    Maliska, Max
    Helman, Elena
    Dorshner, Michael
    Lefterova, Martina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [4] HRD complete: A novel NGS assay for detecting homologous recombination repair (HRR) gene alterations in prostate cancer
    Ye, X.
    Singh, U.
    Cheng, P.
    Guo, Y.
    Wang, J.
    Bell, K.
    Urtishak, K.
    Luo, L.
    Lyu, X.
    Xu, W.
    Huang, Z.
    Chen, X.
    Liu, S.
    Yang, S.
    Shi, W.
    Gormley, M.
    Smirnov, D. A.
    Zhou, L.
    Zhu, C.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S713 - S713
  • [5] Homologous recombination repair pathway alterations and their relationship to homologous recombination deficiency in advanced pancreatic cancer patients
    Patel, Hitendra
    Barrett, Alex
    Mauer, Elizabeth
    Kato, Shumei
    Leibowitz, Benjamin D.
    Singhi, Aatur D.
    Javle, Milind M.
    Lowy, Andrew M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [6] Genetic testing patterns for homologous recombination repair (HRR) alterations in patients with metastatic prostate cancer (mPC): An assessment at the University of Rochester (UR).
    Schaffer, Kerry
    Kyi, Kaitlin
    Lustig, Carol
    Sahasrabudhe, Deepak M.
    Shayne, Michelle
    Baran, Andrea M.
    Fung, Chunkit
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [7] Genomic landscape and homologous recombination repair (HRR) genes analysis in Chinese prostate cancer (PCa) patients.
    Liu, Jianhua
    Lu, Jiantang
    Wang, Jian
    Hu, Yuan
    Li, Binbin
    Zhong, Xuefeng
    Huang, Mengli
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17020 - E17020
  • [8] Tolerability of olaparib (OLA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: PROfound
    Roubaud, G.
    Ozguroglu, M.
    Penel, N.
    Matsubara, N.
    Mehra, N.
    Kolinsky, M. P.
    Procopio, G.
    Feyerabend, S.
    Joung, J. Y.
    Gravis, G.
    Nishimura, K.
    Gedye, C.
    Padua, C.
    Shore, N.
    Thiery-Vuillemin, A.
    Gresty, C.
    Brickel, N.
    Burgents, J.
    Allen, A.
    Fizazi, K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S515 - S516
  • [9] Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations
    Shore, N.
    Oliver, L.
    Shui, I.
    Gayle, A.
    Wong, O. Y.
    Kim, J.
    Payne, S.
    Amin, S.
    Ghate, S.
    [J]. JOURNAL OF UROLOGY, 2021, 205 (04): : 977 - 986
  • [10] Homologous recombination repair (HRR) mutation concordance between liquid biopsy (LB) and tumor tissue by NGS in a real-world prostate cancer (PC) database.
    Shen, John
    Wang, Liang
    Khaki, Ali Raza
    Jimenez, Rafael E.
    Mauer, Elizabeth
    Stoppler, Melissa Conrad
    Chao, Calvin Y.
    Kohli, Manish
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345